Globus Medical NuVasive Merger 2023: A Hospital Procurement Buyer's FAQ

I still remember the purchase order that changed the way I buy medical equipment. It wasn't for a surgical stapler and it wasn't for a spinal implant. It was for a mass spectrometer. The base quote looked like a steal. Then we added installation, validation documents, calibration standards, training, and a service plan, and the 'cheap' option wasn't cheap at all.

That lesson comes back every time I hear about a device merger. If you're a hospital or surgery center buyer looking up NuVasive and Globus Medical, I'll give you the supply-chain version of what happened and what it may mean for your purchasing decisions.

What happened in the Globus Medical NuVasive merger 2023?

Globus Medical and NuVasive announced an agreement in May 2023 and completed it in September 2023. Globus Medical is the continuing public company. NuVasive no longer trades as a separate company, but its technology was absorbed into the combined portfolio. Public announcements used the word 'merger,' while most practical descriptions treat Globus as the acquiring company.

For procurement people, the main takeaway is simpler: If you've been treating NuVasive and Globus Medical as two alternative vendors in a bid, that conversation is over. They now operate as one company. You can still compare them against other competitors, but you are not going to play these two against each other.

Will NuVasive products still be available after the merger?

Active products didn't disappear on day one. NuVasive is especially identified with minimally invasive spine surgery, including lateral approaches such as XLIF. Its clinical services and surgical technique training programs were part of what made it attractive to Globus.

I can't give you a universal list because companies reorganize portfolios over time. What I do as a procurement professional is ask for a current product catalog and a written product continuity statement. If the item code in your contract no longer exists, you want to know before the purchase order is rejected, not in the middle of a case.

Why should procurement care about a device merger beyond the sales pitch?

When vendors merge, sales reps make it sound simple. It rarely is.

Consider what happens under the hood: vendor tax IDs change, ERP vendor records need to be updated, purchase order approvals break, product codes get renamed or retired, insurance certificates expire, service contracts cross legal entities, and rep territories shift.

I've seen surgical teams assume their favorite device is still covered while the contract lists an old vendor ID. That type of confusion doesn't show up on a P&L until somebody starts chasing unpaid invoices. In 2024, when our system reviewed vendor lists after several consolidations, I found three separate IDs for what was already one vendor. That's exactly the kind of mess to avoid.

Why can't I compare NuVasive and Globus Medical based on unit price?

You can, but I wouldn't. Unit price is only part of total cost. The same lesson applies whether I'm buying surgical staplers, a mass spectrometer, or spinal implants.

A low-priced surgical stapler still costs me more per case if it has order minimums, frequent backorders, scheduling conflicts, and extra OR time. I made that mistake earlier in my career. The new vendor's price looked better until I calculated wasted packs, training gaps, and rushed freight.

With the mass spectrometer, the capital quote was just the front door. The cost of ongoing operations was on a different page. It wasn't the vendor being dishonest. It was me not using a total cost framework.

Spine contracts are the same. A screw or interbody cage list price is the visible number. The total cost includes inventory, loaner instruments, sterilization workflow, surgeon education, clinical support, and contract administration.

How do you calculate TCO for a spine implant system?

I don't use a perfect formula. I use a checklist and make every supplier work through it.

• Implant net cost after discounts, rebates, and terms
• Instrumentation: purchase or loaner fees, repair and replacement
• Reprocessing and sterilization costs
• Clinical education, training labs, and OR case support
• Consignment inventory and product expiration
• Freight, logistics, and invoice accuracy
• ERP/data mapping after a merger or vendor change

Each cost may not be huge alone. But if you ignore three or four lines, a deal that looks right rarely is.

After a merger, I add one more line: catalog mapping. If the new company has duplicate SKUs or old NuVasive and Globus codes in different databases, you will pay for it in inventory and staff time.

What should I ask in writing before renewing a NuVasive or Globus Medical contract?

I'm not afraid to ask basic questions. Neither should you.

• Which active product codes are part of the combined agreement?
• Which codes are discontinued or scheduled for phase-out?
• Who provides clinical case support and surgical technique training?
• Are training services and reps included or billed separately?
• How are loaner instrumentation and tray repairs handled?
• What price continuity exists if my current contract has protected pricing?
• What vendor tax ID and remit entity should accounts payable use?

If a rep can't answer all of those, get a written response from the integration team before you sign. NuVasive's clinical services, in particular, are not just brochures. Understand how those services survive the transition.

Does ECG vs EKG have anything to do with NuVasive and Globus Medical?

Indirectly, yes.

ECG and EKG are two abbreviations for the same test: electrocardiogram. ECG follows English; EKG follows the German Elektrokardiogramm. Both are correct, but inventory systems don't always know that. I once found ECG and EKG supplies sitting in separate purchasing categories. The item master didn't identify them as the same thing, so we ended up with duplicate stock and harder spend data.

Why bring that up in an article about a spinal technology merger? Because product catalogs have the same problem. Legacy NuVasive names, legacy Globus names, and combined catalog names can live side by side. If a simple ECG vs EKG spelling difference can create duplicate inventory, imagine what thousands of orthopaedic SKUs can look like without a valid mapping. That is not just an IT issue. It's a procurement cost issue.